Herz Life
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 5
About Herz Life
, trading as Herz Life, is a developer that focuses on pet vaccines based on virus-like particle VLPs technology. Herz Life Science engages in the development of animal and human vaccines. Its main products include feline transabdominal vaccine and castration vaccine. The company generates revenue from providing its pet vaccine products. The company generates revenue from providing its pet vaccine products.
Who invested in Herz Life
5 investors across 4 rounds
See all investors in Herz Life
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Herz Life
Who invested in Herz Life?
Herz Life has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Herz Life raised?
Herz Life has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Herz Life last raise money?
Herz Life's most recent round on record is a Series B, in Jan 2026.
What does Herz Life do?
, trading as Herz Life, is a developer that focuses on pet vaccines based on virus-like particle VLPs technology.
Where is Herz Life headquartered?
Herz Life is headquartered in Shenzhen, China.
Which VCs invest in companies like Herz Life?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Herz Life's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Herz Life? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.